$LAHO - Yesterdays SEC action with LAHO was a blind side

New Post Public Reply Private Reply Replies (0) Message Board
4 MY T
212
$LAHO - Yesterdays SEC action with LAHO was a blind side surprise to all of us.
https://www.investor.gov/additional-resources...uspensions

After I picked myself up off the floor, I started watching the reactions from the shareholders on the other board. I watched and read every post for 17 hours. I'm on the west coast so that's from 7 a.m. till midnight. I wanted to compile the evidence and consult my pillow last night before making a post.

Here are few things this I noticed.

First is the posts from all the doomsayers that were there all day to try and help us salvage what we could monetarily. All of their posts had a common thread in that LAHO is destined for the grey market and its written in stone and there is nothing anyone can do about it. And that the only thing shareholders can do to try and come out of this with a little money is to sell on the cheap right when LAHO starts trading again. (the sky is falling etc.)

And how would one go about doing that? One would have to set their sell orders now for a low price and try and sell it as soon as LAHO starts trading again. Ask yourself who would gain from that? People wanting cheap shares. And how would that play out? From the link above stating how this works with the SEC, we wont know if LAHO will be on the greys or if it will start trading where it left off until the moment we start trading again. And what would happen if there is a bunch of sell orders pre-set ready to sell on the cheap at the opening bell the moment LAHO starts trading again? Drop in pps price by the mass exodus. Who would benefit from that if LAHO starts trading 10 days from now right where we left off yesterday? hmmmmm.

And like clockwork all the bashers voices, posts and guns all fell silent almost in unison. Just like they do on a down day for LAHO hoping to scare some into selling. I mean eerily similar. Remember the mm's pay bashers to bash a stock that they are trying to hold back.

And then this post came along:
https://investorshub.advfn.com/boards/read_ms...=150974882

This smacks of desperation by an mm. All the paid bashers were there all day yesterday all saying the same thing. hmmmm

There has been instances of mm's literally going broke, I mean out of business broke, due to a short squeeze. And LAHO was right on the cusp of a short squeeze that I believe would have taken it to beyond $.01 before retracing. That would have put the hurt to probably more than one mm. Maybe an mm called in a favor from the SEC to save their rear end.


Second is I spoke with Sean at the auditors office yesterday. He told me that the audit was proceeding as planned regardless of yesterdays SEC action. If this were a scam, why would the company spend the money to finish the audit? It would serve no purpose.

Call them if you like.
Fruci & Associates
Phone: 509 624 9223



Third is look at the company and in particular the CEO:
http://www.lans.holdings/about.html

To me, the numbers don't add up to a scam.

The paid bashers are telling me that the company is going to take the shareholders for a few bucks and throw away the funding they need, via going public, to further their work?

To me, the numbers don't add up to a scam.

The paid bashers are telling me that the company is going to take the shareholders for a few bucks and throw away the future earnings from the shares they own and risk lawsuits up the wazzoo and damage their reputation with the medical community for a few measly bucks by scamming the shareholders?

To me, the numbers don't add up to a scam.

The companies both do their DD well in advance before entering into a binding LOI to have this be more than just a bump in the road. I'll have to see proof of a scam, other than the paid bashers touting it, for me to believe otherwise.

To me, the numbers don't add up to a scam.

Too many paid bashers on the other board yesterday trying to save me from myself by instructing me to get my sell orders in right now for a bargain basement price all in unison for me to believe them. Especially when we wont know how this ends up, grey market or trading as usual, until the very moment LAHO starts trading again.

To me, the numbers don't add up to a scam.


All IMO of course.


P.S. I'm holding my sell orders right where they are at now. I'll hold my cards and wait for the opening bell when LAHO starts trading again before I make any changes. All the paid bashers yesterday were just a little too coincidental for me.

As I am fond of saying "I have heard of a coincidence, I just haven't seen one yet."
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 956

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 251

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 295

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 471

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 245

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 307

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading

Top 5 Most Recently Viewed Articles

Explore Consciousness at the CONTACT Modalities XPO Gathering

Updated Category News Views 271

CONTACT Modalities XPO: A Unique Gathering for Consciousness Exploration Prepare to embark on a transformative journey of self-discovery and exploration at the CONTACT Modalities XPO. This gathering promises to bring together passionate individuals eager to delve into consciousness studies through engaging sessions and workshops. The event will be held at the stunning...

Continue Reading
Green Thumb Industries Set to Unveil Q3 2025 Financial Overview

Updated Category News Views 266

Green Thumb Industries to Report Third Quarter Financial Results Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), a standout in the cannabis consumer packaged goods sector, is poised to unveil its financial performance for the third quarter of 2025. The eagerly anticipated announcement will occur after market hours on November 5, 2025. Known for its growth and...

Continue Reading
Boussard & Gavaudan Holding: Estimated NAV Update

Updated Category News Views 129

About Boussard & Gavaudan Holding Limited Boussard & Gavaudan Holding Limited aims to keep shareholders informed—plain and simple. The company provides timely updates on its estimated net asset values (NAVs) and on the performance of its Euro and Sterling share classes, so you can track what matters without guesswork. How the Estimated NAV Is Determined Each month, the...

Continue Reading
Booming Yacht Rental Market Set to Surpass $13 Billion Milestone

Updated Category News Views 93

The yacht rental market hit a turning point, projected to exceed $13.1 billion in value—back when those forecasts came out, traders were buzzing about it. The allure of luxury travel had folks flocking to yacht rentals like moths to a flame. Market Drivers: Luxury Demand or Overhyped? High-net-worth individuals fueled the demand for yacht rentals, as they sought...

Continue Reading
Hellenic Telecom Completes Share Repurchase, Strengthening Value

Updated Category News Views 156

Hellenic Telecom's Successful Share Buyback Program Hellenic Telecommunications Organization S.A. (ATH:HTO), widely recognized as OTE, has recently finished a significant week of share repurchasing. In a strategic move, the company acquired a total of 414,128 shares, investing approximately €6.16 million at an average price of €14.87 per share. Understanding the Share...

Continue Reading